HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

• Status: Recruiting
• Trial end date: 2025-04-01

Summary

This is a study to use glucarpidase prophylactically to treat methotrexate induced toxicities in lymphoma patients with cerebral involvement.

• Phase: Phase 2

Details

• Lead Sponsor: Fox Chase Cancer Center